Pain, Psychological, and Endocannabinoid Responses to Yoga in Breast Cancer Survivors With Chemotherapy-induced Neuropathic Pain

NCT ID: NCT04075097

Last Updated: 2020-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-31

Study Completion Date

2020-02-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the acute effect of aerobic exercise and yoga on pain, plasma levels of endocannabinoids, and mood (i.e., mood disturbance and anxiety). Participants will complete three separate sessions on different days. The first session is a familiarization session in which participants complete questionnaires and are familiarized with the experimental protocols. During the second and third sessions, outcomes are measured before and after the participants complete either 44 minutes of moderate aerobic exercise (i.e., walking on a treadmill) or 44 minutes of yoga.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Chemotherapy-induced Peripheral Neuropathy Neuropathic Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

The proposed study is an acute, single group, crossover pilot study where participants will complete two different experimental conditions: aerobic exercise and yoga.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aerobic exercise

44 minutes of moderate intensity walking on a treadmill.

Group Type EXPERIMENTAL

Aerobic exercise

Intervention Type BEHAVIORAL

1 session

Yoga

44 minutes of Iyengar yoga.

Group Type EXPERIMENTAL

Iyengar yoga

Intervention Type BEHAVIORAL

1 session

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic exercise

1 session

Intervention Type BEHAVIORAL

Iyengar yoga

1 session

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of breast cancer (stage 0-III),
* no evidence of active disease (i.e., recurrence, bone metastases, etc),
* presence of painful polyneuropathy, with onset coinciding or developing after receiving chemotherapy agents that in the opinion of the research team is likely to have caused such symptoms,
* at least six months since last active cancer treatment, with no further planned treatment (Note. active treatment is defined as surgery, chemotherapy, or radiation),
* the participant agrees to use the safety stop feature on the treadmill if needed,
* at least 18 years of age,
* and their physicians has provided consent for them to participate in yoga and aerobic exercise sessions.

Exclusion Criteria

* Undergoing current chemotherapy or radiation treatment for cancer,
* taking anticoagulant therapy,
* uncontrolled medical conditions (i.e., uncontrolled hypertension, heart disease, stage 4 liver disease, end-stage renal disease, end-stage pulmonary disease, etc),
* stroke or myocardial infarction in the past 6 months,
* being pregnant or planning to become pregnant,
* severe mobility constraints (e.g., confined to a wheelchair),
* having a history of light headedness or fainting during blood draws or physical activity.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

American College of Sports Medicine

OTHER

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kelli Koltyn, PhD

Role: PRINCIPAL_INVESTIGATOR

Professor of Kinesiology- Exercise Psychology, University of Wisconsin-Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin-Madison Natatorium

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A176000

Identifier Type: OTHER

Identifier Source: secondary_id

EDUC/KINESIOLOGY/KINESIOLOG

Identifier Type: OTHER

Identifier Source: secondary_id

UW18057

Identifier Type: OTHER

Identifier Source: secondary_id

2018-1518

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Yoga During Chemotherapy Study
NCT02442635 COMPLETED NA
Yoga to Reduce Cancer Fatigue
NCT00583739 COMPLETED PHASE2